Literature DB >> 33914142

Iron-sensitive magnetic resonance imaging in Parkinson's disease: a systematic review and meta-analysis.

Se Jin Cho1, Yun Jung Bae2, Jong-Min Kim3, Hyun Jin Kim4, Sung Hyun Baik1, Leonard Sunwoo1, Byung Se Choi1, Cheolkyu Jung1, Jae Hyoung Kim1.   

Abstract

OBJECTIVE: To evaluate the diagnostic performance of iron-sensitive sequences targeting the substantia nigra for distinguishing patients with Parkinson's disease from control participants and to identify factors causing heterogeneity.
METHODS: A systematic literature search in the Ovid-MEDLINE and EMBASE databases was performed for studies reporting the relevant topic before March 6, 2020. The pooled sensitivity and specificity values with their 95% confidence intervals were calculated using bivariate random-effects modeling. Subgroup and meta-regression analyses were also performed to determine factors influencing heterogeneity affecting the diagnostic performance among the clinical, MRI, and analytic characteristics.
RESULTS: A total of 22 articles including 1126 patients with Parkinson's disease and 933 control participants were enrolled in this systematic review and meta-analysis. Of those, 12 studies used objective analyses of quantitative susceptibility measurements, and 10 visually assessed the nigrosome-1 in subjective analyses. Iron-sensitive nigral magnetic resonance imaging showed a pooled sensitivity of 92% (95% confidence interval 88-95%) and a pooled specificity of 90% (95% confidence interval 81-95%). According to subgroup and meta-regression analyses, a longer mean disease duration in patients with Parkinson's disease (≥ 5 years), subjective analysis, a smaller size of pixel (< 0.6 mm2), a larger flip angle (> 15°), a smaller slice thickness (≤ 1 mm), and specific targeting of the substantia nigra pars compacta improved the diagnostic performance.
CONCLUSION: Iron-sensitive nigral magnetic resonance imaging had a favorable diagnostic performance in discriminating patients with Parkinson's disease from control participants. Subjective analytic methods remain superior to objective approaches. Further improvements of the spatial resolution and contrast-to-noise ratio to specifically target the nigrosome-1 with objective analytic methods will be needed.

Entities:  

Keywords:  Magnetic resonance imaging; Meta-analysis; Parkinson disease; Systematic review

Year:  2021        PMID: 33914142     DOI: 10.1007/s00415-021-10582-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  40 in total

1.  Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2.

Authors:  Jeam Haroldo Oliveira Barbosa; Antonio Carlos Santos; Vitor Tumas; Manju Liu; Weili Zheng; E Mark Haacke; Carlos Ernesto Garrido Salmon
Journal:  Magn Reson Imaging       Date:  2015-02-24       Impact factor: 2.546

2.  The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.

Authors:  Jonathan J Deeks; Petra Macaskill; Les Irwig
Journal:  J Clin Epidemiol       Date:  2005-09       Impact factor: 6.437

3.  The early diagnosis of Parkinson's disease through combined biomarkers.

Authors:  Xin-Qiao Chen; Jian-Ping Niu; Rui-Qiang Peng; Ye-Hua Song; Na Xu; Yi-Wen Zhang
Journal:  Acta Neurol Scand       Date:  2019-06-13       Impact factor: 3.209

4.  MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease.

Authors:  Mirco Cosottini; Daniela Frosini; Ilaria Pesaresi; Mauro Costagli; Laura Biagi; Roberto Ceravolo; Ubaldo Bonuccelli; Michela Tosetti
Journal:  Radiology       Date:  2014-02-26       Impact factor: 11.105

5.  Multiparametric MR imaging of Parkinsonisms at 3 tesla: Its role in the differentiation of idiopathic Parkinson's disease versus atypical Parkinsonian disorders.

Authors:  S F Calloni; G Conte; S Sbaraini; R Cilia; V E Contarino; S Avignone; G Sacilotto; G Pezzoli; F M Triulzi; E Scola
Journal:  Eur J Radiol       Date:  2018-11-01       Impact factor: 3.528

Review 6.  Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECT.

Authors:  Yun Jung Bae; Jong-Min Kim; Eunhee Kim; Kyung Mi Lee; Seo Young Kang; Hyun Soo Park; Kyeong Joon Kim; Young Eun Kim; Eung Seok Oh; Ji Young Yun; Ji Seon Kim; Hye-Jin Jeong; Beomseok Jeon; Sang Eun Kim
Journal:  Mov Disord       Date:  2016-03-17       Impact factor: 10.338

7.  Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease.

Authors:  Zenghui Cheng; Naying He; Pei Huang; Yan Li; Rongbiao Tang; Sean K Sethi; Kiarash Ghassaban; Kiran Kumar Yerramsetty; Vinay Kumar Palutla; Shengdi Chen; Fuhua Yan; E Mark Haacke
Journal:  Neuroimage Clin       Date:  2019-11-20       Impact factor: 4.881

8.  Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility Mapping.

Authors:  M Azuma; T Hirai; K Yamada; S Yamashita; Y Ando; M Tateishi; Y Iryo; T Yoneda; M Kitajima; Y Wang; Y Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-28       Impact factor: 3.825

9.  Aging Disrupts the Circadian Patterns of Protein Expression in the Murine Hippocampus.

Authors:  Paula Adler; Cheng-Kang Chiang; Janice Mayne; Zhibin Ning; Xu Zhang; Bo Xu; Hai-Ying Mary Cheng; Daniel Figeys
Journal:  Front Aging Neurosci       Date:  2020-01-15       Impact factor: 5.750

10.  Conducting systematic reviews of diagnostic studies: didactic guidelines.

Authors:  Walter L Devillé; Frank Buntinx; Lex M Bouter; Victor M Montori; Henrica C W de Vet; Danielle A W M van der Windt; P Dick Bezemer
Journal:  BMC Med Res Methodol       Date:  2002-07-03       Impact factor: 4.615

View more
  1 in total

Review 1.  [MRI Findings in Parkinson's Disease: Radiologic Assessment of Nigrostriatal Degeneration].

Authors:  Yun Jung Bae; Jong-Min Kim; Byung Se Choi; Yoo Sung Song; Yoonho Nam; Se Jin Cho; Jae Hyoung Kim; Sang Eun Kim
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2022-05-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.